ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
Cell Death Dis
; 10(2): 33, 2019 01 15.
Article
in En
| MEDLINE
| ID: mdl-30674889
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Transcription Factors
/
Histone-Lysine N-Methyltransferase
/
LIM-Homeodomain Proteins
/
Zinc Finger E-box-Binding Homeobox 1
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Female
/
Humans
/
Male
Language:
En
Journal:
Cell Death Dis
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom